Adenosine diphosphate receptor inhibitor
Adenosine diphosphate (ADP) receptor inhibitors are a drug class of antiplatelet agents, used in the treatment of acute coronary syndrome (ACS) or in preventive treatment for patients who are in risk of thromboembolism, myocardial infarction or a stroke. These drugs antagonize the P2Y12 platelet receptors and therefore prevent the binding of ADP to the P2Y12 receptor. This leads to a decrease in aggregation of platelets, prohibiting thrombus formation. The P2Y12 receptor is a surface bound protein found on blood platelets. They belong to G protein-coupled purinergic receptors (GPCR) and are chemoreceptors for ADP.
Wikipage redirect
Link from a Wikipage to another Wikipage
primaryTopic
Adenosine diphosphate receptor inhibitor
Adenosine diphosphate (ADP) receptor inhibitors are a drug class of antiplatelet agents, used in the treatment of acute coronary syndrome (ACS) or in preventive treatment for patients who are in risk of thromboembolism, myocardial infarction or a stroke. These drugs antagonize the P2Y12 platelet receptors and therefore prevent the binding of ADP to the P2Y12 receptor. This leads to a decrease in aggregation of platelets, prohibiting thrombus formation. The P2Y12 receptor is a surface bound protein found on blood platelets. They belong to G protein-coupled purinergic receptors (GPCR) and are chemoreceptors for ADP.
has abstract
Adenosine diphosphate (ADP) re ...... s coronary intervention (PCI).
@en
Wikipage page ID
25,032,880
page length (characters) of wiki page
Wikipage revision ID
1,020,693,228
Link from a Wikipage to another Wikipage
wikiPageUsesTemplate
hypernym
comment
Adenosine diphosphate (ADP) re ...... nd are chemoreceptors for ADP.
@en
label
Adenosine diphosphate receptor inhibitor
@en